Status of the cofactor identity in copper oxidative enzymes  by Klinman, J.P. et al.
Vahmc 282, rwnbcr 1, I-J PEls OS)hQO 
@3 1091 Fccicmrian of Eurspenn Biochcmieal Soclcricd 00145793/9l/si3,$0 
AlR%‘lS OOl457939lQO309K 
hprll l%Jl 
Status of the cofactor identity in copper oxidative enzymes 
J.P. KlinnxuQ, D.M. Dooley2, J.A. Duinti3, P.F. Knowles4, B. MondoviS and J.J. Villafran& 
Reccivcd 29 January 1991 
Much conflicting data have appeared in the litcraturc regarding the nature of the active site structures responsible for catalysis in thtcc classcr 
of copper cneymcs: the copper amine oxidascs, dopamine b-monooxygenasr and galactose oxidasc. Although pyrroloquinolinc quinonc has been 
proposed to be the active site cofactor in each instance, new findings indicate this is not the case. Instead. recently available data indicate a spectrum 
of strategies far substrate activation, which range from direct metal catalysis (dopamine /I-monooxygcnase) to the involvement of protein-derived 
radicals (galactosc oxidasc) and protein-derived quinoncs (copper amine oxidases). 
Copper protein; Pyrroloquinolinc quinonc; Topa yuinonc 
1. INTRODUCTION 
A meeting on the subject of ‘Copper in Biological 
Systems’ was held on September 23-28, 1990 in 
Manziana, Italy. This meeting brought together a 
critical mass of investigators who have been pursuing 
cofactor structure in copper oxidative nzymes over the 
past five to ten years. During this period, much con- 
flicting data have appeared in the literature regarding 
the true nature of the active site structures responsible 
for catalysis in three classes of copper enzymes: the cop- 
per amine oxidases, dopamine ,&monooxygenase and 
galactose oxidase, At tlie present ime considerable con- 
fusion exists among investigators not directly involved 
in studies of these enzymes. The goal of this paper is a 
clarification of the status of our knowledge regarding 
each system. 
2. COPPER AMINE OXIDASES 
Copper amine oxidases are widespread and have been 
studied from bacteria, plants and mammals. Historical- 
ly, three different cofactor structures have besn propos- 
ed for these enzymes. 
2. I, Pyridoxal phosphate 
A prominent feature of the copper amine oxidases is 
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their reactivity toward carbonyl reagents such as phenyl- 
hydrazine, to yield chromophoric derivatives. In this 
context, early investigations focused on a role for 
pyridoxal phosphate as the reactive carbonyl [I]. 
However, the presence of this cofactor has never been 
directly demonstrated. Both NMR spectroscopy and 
resonance Raman studies have been carried out. on 
several amine oxidases. ” P-NMR studies of porcine 
serum amine oxidase failed to detect he expected signal 
for the phosphate group of pyridoxal phosphate [2], 
although such studies cannot rule out pyridoxal itself. 
Resonance Raman spectra of phenylhydrazine and 
nitrophenylhydrazine derivatives of amine oxidases 
from porcine and bovine sera, pea seedlings, porcine 
kidney and Arthrobacter P1 indicate different spectra 
from the analogous derivatives of pyridoxal phosphate 
[3]. Chemical evidence also argues strongly against a 
simple carbonyl cofactor. Amine substrates have been 
shown to be competitive with regard to hydrazine in- 
hibitors of amine oxidases and, as such, are expected to 
form Schiff base intermediates. Yet no tritium transfer 
to enzyme could be dernonstrated upon incubation of 
bovine serum amine oxidase with substrate and NaBT4 
[4]. More recently, it has been shown that NaCNBH3 
treatment of bovine serum amine oxidase with substrate 
leads to the incorporation of one mol of ‘“C-labeled 
substrate per mol of enzyme subunit ‘concomitant with 
enzyme inactivation. Once again, no iransfer of tritium 
from NaCNk3Ts to enzyme could be detected, leading to 
the proposal of a dicarbonyl-type cofactor structure 
1 
which would release rritium from the initially reduecd 
complex [S], The numerous lines of investigation, 
outlined above, argue strongly against a role for 
pyridoxal phosphate in the copper amine oxidasea, 
Wowcver, reports of this cofactor in swum amine OX- 
idaae have appeared in the recent literature [6,7]. 
2.2. Pyrroloquinoline qrtirione 
Two independent reports, published in 1984 (8,9], 
focused attention on a newly discovered bacterial co- 
factor, pyrrolsquinolinc quinone, as the covnlenrly 
bound cofactor in bovine serum amine oxidnse. The 
approach developed by the Delft group [IO] involved 
prolonged incubation of enzyme with dinitrophesyl- 
hydrazinc in the presence of oxygen. Pronasc digestion 
of derivatized enzyme was found to release a product 
which showed the same retention time on HPLC and 
‘H-NMR spectrum as an authentic addact of pyrrolo- 
quinoline quinone with dinitrophenylhydrazine. Extcn- 
sion of this methodology to a number of other amine 
oxidases, which include kidney amine oxidase [IO], lysyl 
oxidase [ 1 I], methylamine oxidasc from Arrhrobacm 
Pl [ 121 and amine oxidase from pea seedlings [13], 
yielded similar results. Resonance Raman spectroscopy 
of phenylhydrazone derivatives of various amine ox- 
idases was also pursued, While protein-dinitrophenyl- 
hydrazone spectra showed a much greater similarity to 
the dinitrophenylhydrazone derivative of pyrrolo- 
quinoline quinone than pyridoxal phosphate, signifi- 
cant differences in the intensity and position of peaks 
were apparent [14]. Subsequent comparison of reso- 
nance Raman spectra of 2-hydrazinopyridine and p- 
nitrophenylhydrazine d rivatives has indicated that pyr- 
roloquinoline is not the cofactor in amine oxidases [3]. 
It is now believed that the combination of prolonged 
treatment of enzyme with phenylhydrazine, followed by 
pronase digestion, leads to the formation of a cieriuative 
of a native structure and does not represent pyrrolo- 
quinoline quinone itself at the enzyme active site. The 
chemistry which produces pyrrol,oquinoline quinone is 
unknown and in need of further study. The requirement 
for oxygenation of reaction solutions to produce high 
yields of pyrroloquinoline quinone-like molecules [1 O] 
suggests the importance of redox reactions. Buechi et 
al. have already shown that tyrosine can be converted to 
pyrroloquinoline quinone in an oxidative manner [151. 
2.3. Topa quinone 
A recent study has focused on the proteolysis of a 
[‘%]phenylhydrazine derivative of bovine serum amine 
oxidase under mild conditions [16]. These studies used 
a highly purified preparation of enzyme, which shows a 
titration end point with phenylhydrazine close to one 
mol incorporated per enzyme subunit. Others authors 
had titrated only one mol of phenylhydrazine p r dimer 
using similar enzyme preparations [17]; the relative 
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rcncrivity of the two curbonyl groupr wilt be discussed 
below, HPLC purification of a thermolytie digestion 
indicated one major radioactive peptide peak in ca, 
40% yield. Micro-Edman sequencing ur this peptidc 
gave: lau, asn, blank, asp, tyr. Subsequent charaetrrizn- 
tion of this pentapeptide by mass pectromcrry and ‘H- 
NMR led to assignment of the blank at position 3 ta the 
oxidized form of a 2,4,S-rrihydroxyphenylalanine 
residue, referred to as topa quinone [16), This assign- 
ment has been confirmed by chemical synthesis of a 
topa quinonc model compound and by comparison of 
this model to the protein-derived peptidc using ‘H- 
NMR [IG] and resonance Raman spectroscopy [IS]. A 
total of 75% of the radiolabel originally associated with 
protein could be recovered from the HPLC. A second 
radiolabeled pcptide, obtained in ea. 10% yield, was 
scqucnced and found to be comparable to the original 
pcntapcptide (with the addition of two amino acids at 
its C-terminus). Thus, a total of ca, 50% of prorein- 
associated radiolabel can be unambiguously assigned co 
the phcnylhydrazone of topa quinone [191. Since all of 
the protein-bound phcnylhydrazine shows similar 
chromophoric properties, it seems unlikely that the re- 
maining C-14 in derivatized enzyme is bound to a func- 
tional group different from topa quinone. In a recent 
study [18], resonance Raman spectra for the 
phenylhydrazine and nitrophenylhydrazine d rivatives 
of bovine serum amine oxidase were compared to 
spectra for the respective, protein-derived peptides. The 
high degree of similarity observed between peptide and 
protein spectra indicates that the topa quinone in 
isolated peptide is not an artifact of the isolation pro- 
cedure, Since the above described studies were carried 
out on a single amine oxidase (from bovine serum), it is 
important o question the generality of topa quinone as 
an active site structure in copper amine axidases. At the 
current ime, both resonance Raman spectroscopy [ 181 
and sequencing of active site peptides [19] support a 
structure similar to topa quinonc in the amine oxidases 
from porcine serum and kidney, pea seedling, yeast and 
bacteria. Lysyl oxidase may be an important exception 
to this generalization, since no sequence homology to 
active site peptides obtained from other amine oxidases 
can be discerned by examination of the lysyl amine ox- 
idase c-DNA derived protein sequence [20]. 
One unresolved issue concerns the relative reactivity 
of the two prosthetic groups present in dimeric amine 
oxidase. While some of us find similar reactivity at both 
sites [21 J, others observe biphasic kinetics and/or varia- 
tions in spectral properties following derivatization of 
bovine [17,22] and porcine serum amine oxidase [23]. 
The structural basis for the observation of differential 
reactivities at the two active site cofactors is in need of 
clarification. A comparative study of the ratio of cop- 
per to active site prosthetic groups, using enzyme 
preparations from different laboratories, may help to 
rationalize xisting discrepancies (cf. [24]). 
The kinetic mcrhnninm af” dupeminc &msnooxygen- 
asc has been rlgarously pursued through a combination 
of kinetics and spcctrsseopy [25], Results from these 
studies how that rcdox cycling at the two capper ntoms 
per subunit can account for the catnlycic mechanism. A
possible ralc for nn organic cafnctor wns sug~esred 
through the use OF phcnylhydrazine derivatives as car- 
banyt renpcntx [26], In these studies, Duine ancl co- 
workers [2G] isolated a pyrroloquinolinc quinonc-like 
mo1eculc which was shown to have the same retention 
time on MPLC as an autlienric pyrroloquinoline 
quinone derivnlivc, Phcnylhydrazine had previously 
been shown to act as a stoichiomrtric, m@ehnnism- 
bnscd inhibitor, leading to covalent labeling of protein 
(271. Subsequently, Villafrnnca and co-workers [28] 
focused on the isolation and characterization of labeled 
active site pcptidcs. These stuc,ies demonstrated label- 
ing of tyrosinc and histidine by phenylhydrazinc; no 
pyrroloquinolinc quinone could be detected, Variances 
in experimental results between the laboratories of 
Duine and Villafranca are actribured to the very 
different experimental conditions used by the two 
laboratories for the derivatization of doRamine B- 
monooxygenase byphcnylhydrazine. lr is r&v belicvcd 
that pyrroloquinoline quinone, as such, is absent, but 
that an analogous tructure may be formed following 
treatment of enzyme under the prolonged conditions 
employed by Duine and co-workers. 
Vulumc 281. nunrbcr I 
procedure (U.W, Green nnd SA. Buinc, unpublished 
results), Thus, all available vidence paints tawnrrl the 
pnrricipzxtian of n tyrosyl rndical in rha catulytie 
meelinniam of galnctosr oxidasr. 
5. FINAL COMMENTS 
The authors wish to point out the exciting new 
dcvclopmcnts which have emerged concerning the use 
of amino acid derivatives as redox cofactors. With 
regard to copper containing enzymes, a spectrum of 
strategies exist for substrate activation: these range 
from direct metal catalysis (dapomine fl~monooxy- 
gcnasc) to the involvement of protein-dcrivcd radicals 
(galnctosc sxidasc) and prorein.derivcd quinoncs (cop- 
per amine oxidascs). 
4, CALACTOSE OXIDASE 
Unlike dopamine @-monooxygcnase, galactose 
oxidase is a monomeric enzyme containing a single cop- 
per atom per polypeptide chain [29,30]. In this context, 
it has been difficult to explain an enzyme-catalyzed, 
two electron oxidation of substrate, It has been known 
for some time that galactose oxidase can be oxidatively 
activated, through a process originally suggested to in- 
volve Cu(III) formation [31]. Because the redox poten- 
tial for Cu(I1) --t Cu(II1) is expected to be very high [32], 
the presence of such a species in a protein active site has 
been controversial. Independent reports in 1988 sug- 
gested the involvement of an additional redox cofactor, 
either pyrroloquinoline quinone (Duine and co-workers 
[33]) or a protein derived radical (Whittaker and co- 
workers [34]). A recent, high-resolution x-ray structure 
for galactose oxidase unambiguously eliminates the 
possibility of an active site quinone, revealing, instead, 
active site t.yrosines [35]. This is consistent with a recent 
EPR characterization of the copper-free form of galac- 
tose oxidase, which implicates atyrosyl radical [36]. Us- 
ing ribonucieotide reductase as a modei system for 
tyrosyl radical containing proteins, Duine and co- 
workers have been able to produce pyrroloquinoline 
quinone-like derivatives using their hexanol extraction 
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